1-(9-fluorenyl)methyl chloroformate has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akatsu, H; Inoue, K; Muguruma, Y; Noda, T; Tsutsui, H | 1 |
| Cai, Y; Chen, YL; Duan, GL; Li, Y; Tong, XY; Xie, MF; Zhou, W | 1 |
2 other study(ies) available for 1-(9-fluorenyl)methyl chloroformate and Alzheimer Disease
| Article | Year |
|---|---|
Widely targeted metabolomics of Alzheimer's disease postmortem cerebrospinal fluid based on 9-fluorenylmethyl chloroformate derivatized ultra-high performance liquid chromatography tandem mass spectrometry.
Topics: Aged, 80 and over; Alzheimer Disease; Biomarkers; Chromatography, High Pressure Liquid; Female; Fluorenes; Humans; Male; Metabolome; Metabolomics; Tandem Mass Spectrometry | 2018 |
High-performance liquid chromatographic determination of memantine hydrochloride in rat plasma using sensitive fluorometric derivatization.
Topics: Alzheimer Disease; Animals; Chromatography, High Pressure Liquid; Dopamine Agents; Fluorenes; Humans; Memantine; Rats; Rats, Wistar | 2011 |